Introduction Despite advances in surgical and anaesthetic techniques, non-cardiac surgery still has a significant mortality. We hypothesised that pre-operative troponin levels might predict post-operative mortality. Methods Patients undergoing elective and urgent/emergency non-cardiac surgery excluding minor procedures were retrospectively assessed for known vascular disease (defined by diagnostic imaging or previous intervention rather than clinical assessment) and vascular risk factors including hypertension, treatment with lipid-modifying agents (irrespective of agent or dose) and chronic lung disease.
Pre-operative high-sensitivity troponins and routine preoperative bloods were recorded. Six-and twelve-month mortality data were collected; independent predictors of mortality and associations between pre-operative patient characteristics and pre-operative troponin were determined. Results 993 patients were assessed; 13% had an elevated preoperative troponin with 3%>50 ng/L. 825 (83%) were elective patients; 8.6% had an elevated pre-operative troponin.
Six-month mortality was 4.2% and 5.9% at twelve months. Elevated pre-operative troponin was associated with higher post-operative mortality; 2.5%, 12.5% and 25% for a troponin <17 ng/L, 17 -49 ng/L and >50 ng/L respectively (figure 1). This trend was also evident at twelve months; 3.7%, 16.3% and 37% for the same troponin bands (figure 2). Lipid-modifying agents were independently associated with a lower rate of pre-operative troponin release (HR 0.446 (0.232 -0.857) p=0.015).
Impaired renal function (assessed as a continuous variable), emergency presentation and pre-operative troponin levels were independent predictors of six-and twelve-month mortality with emergency presentation the strongest predictor by hazard ratio (table 1) . Age over 75 independently predicted twelvemonth mortality only. Conclusion The role of pre-operative troponin monitoring and the prevalence of pre-operative troponin has not previously been established on an all-comer population. Pre-operative troponin level greater than 50 ng/L is an independent predictor of six and twelve-month mortality following non-cardiac surgery in an all-comers cohort although the mechanism of troponin release is not clear.
The lower rate of troponin release associated with lipidmodifying medication has been seen in other studies (1). We hypothesise the known anti-inflammatory effects of statins may indicate a systemic inflammatory process responsible for the troponin release rather than unstable coronary disease. Further studies to assess this in the elective population may be useful to target pre-operative interventions. Introduction The Rapid Access Chest Pain Clinics (RACPC) system has become an important way of assessing patients who present with chest pain to their primary care physician. Based on standard protocols up to 50% are discharged with a diagnosis of non-cardiac pain and re-assured. This abstract reviews the longer term outcomes of such patients. Aims and Objectives We sought to determine the proportion of patients discharged from the University Hospital of Leicester (UHL) RACPC with non-cardiac chest pain, and retrospectively determine the outcomes of these patients specifically with regards to mortality, re-admission with acute coronary syndromes or re-attendance at a cardiology outpatient clinic. Methods All patients reviewed in the UHL RACPC and discharged with a diagnosis of non-cardiac chest pain between 2010 and 2013 were followed-up for 1 year. Data regarding hospital readmission was obtained from UHL Hospital Episode Statistics. The coded diagnosis for cardiac readmissions was confirmed with review of discharge summaries. Clinic letters and investigations were reviewed for patients who were subsequently referred to cardiology outpatients following discharge from RACPC.
Results Of 7066 patients seen in the RACPC clinic between 2010-2013. 3253 were discharged with a diagnosis of noncardiac chest pain (46.0%), and consistent/year (2010-2011%-45.8%, 2011-2012%-47.0%, 2012-2013%-45.2%) . Outcomes are summarised in fig 1. Follow-up was 12 monthsfor death and re-admission, and 6 months for re-attendance at cardiology OP clinic. Readmission: The 12 month acute readmission rate for patients discharged was 1.4% (44/3253) with most for non-cardiac causes (28 patients). Only 8 patients were readmitted for acute coronary syndromes (0.24% of discharged patients). Non-ACS cardiac admissions (8 patients) were predominantly for arrhythmias (table 1) . None of the patients readmitted with ACS or non-ACS cardiac condition died within 1 year of discharge from RACPC. Re-attendance at cardiology outpatients: 28 patients (0.86%) were seen in the cardiology outpatient clinic 6 months following discharge from RACPC. 74% of these patients underwent further cardiac investigations (fig 2) , however only 7 patients were diagnosed with ischaemic heart disease (0.2% of patients discharged from RACPC). Mortality: 11 patients (0.3%) died within one year of discharge from the RACPC. Median time from RACPC attendance to death: 210 days (IQR=128 -285 days). The causes of death included metastatic cancer (4), Large PE secondary to pancreatic cancer (1), acute haemorrhagic pancreatitis (1), Sepsis (2). One recorded death from MI was in the context of sepsis, DKA and CVA. Conclusions These data show that thorough and accurate assessment of patients with chest pain in the RACPC leads to good outcomes with a subsequent very low hospital admission rate for ACS These are reassuring data.
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